Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

SELL
$27.42 - $43.63 $117,193 - $186,474
-4,274 Reduced 35.77%
7,674 $239,000
Q1 2022

May 10, 2022

SELL
$36.48 - $52.22 $53,260 - $76,241
-1,460 Reduced 10.89%
11,948 $491,000
Q4 2021

Feb 08, 2022

BUY
$33.11 - $55.01 $89,363 - $148,471
2,699 Added 25.2%
13,408 $583,000
Q3 2021

Nov 12, 2021

SELL
$50.07 - $66.05 $354,946 - $468,228
-7,089 Reduced 39.83%
10,709 $536,000
Q2 2021

Aug 13, 2021

BUY
$56.61 - $80.46 $79,367 - $112,804
1,402 Added 8.55%
17,798 $1.12 Million
Q1 2021

May 14, 2021

BUY
$86.23 - $125.19 $177,633 - $257,891
2,060 Added 14.37%
16,396 $1.52 Million
Q4 2020

Feb 09, 2021

BUY
$79.17 - $111.47 $399,966 - $563,146
5,052 Added 54.42%
14,336 $1.29 Million
Q3 2020

Nov 13, 2020

BUY
$81.91 - $134.94 $202,317 - $333,301
2,470 Added 36.25%
9,284 $959,000
Q2 2020

Aug 03, 2020

BUY
$54.33 - $89.52 $370,204 - $609,989
6,814 New
6,814 $539,000
Q1 2020

May 15, 2020

SELL
$49.34 - $68.76 $364,671 - $508,205
-7,391 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$51.21 - $59.06 $55,511 - $64,021
1,084 Added 17.19%
7,391 $399,000
Q3 2019

Nov 12, 2019

BUY
$40.6 - $57.2 $7,551 - $10,639
186 Added 3.04%
6,307 $330,000
Q2 2019

Aug 13, 2019

SELL
$39.92 - $53.86 $4,910 - $6,624
-123 Reduced 1.97%
6,121 $296,000
Q1 2019

May 15, 2019

BUY
$48.23 - $66.16 $9,308 - $12,768
193 Added 3.19%
6,244 $315,000
Q4 2018

Feb 14, 2019

SELL
$55.63 - $73.24 $27,981 - $36,839
-503 Reduced 7.67%
6,051 $359,000
Q3 2018

Nov 14, 2018

SELL
$52.05 - $66.51 $23,266 - $29,729
-447 Reduced 6.38%
6,554 $431,000
Q2 2018

Aug 13, 2018

BUY
$48.33 - $55.64 $78,826 - $90,748
1,631 Added 30.37%
7,001 $353,000
Q1 2018

May 14, 2018

SELL
$44.44 - $54.39 $29,908 - $36,604
-673 Reduced 11.14%
5,370 $283,000
Q4 2017

Feb 14, 2018

BUY
$37.77 - $47.75 $228,244 - $288,553
6,043
6,043 $281,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $515M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.